- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/4 | 3.7 | -5.7 | 2.55 | 15.15 | 7.36 | 10.94 | N/A | - | ||
| 2026/3 | 3.92 | 17.97 | 6.01 | 11.45 | 9.01 | 11.45 | 0.68 | - | ||
| 2026/2 | 3.32 | -21.06 | 6.88 | 7.53 | 10.64 | 11.45 | 0.68 | - | ||
| 2026/1 | 4.21 | 7.3 | 13.8 | 4.21 | 13.8 | 11.39 | 0.69 | - | ||
| 2025/12 | 3.92 | 20.21 | 7.85 | 42.78 | 5.04 | 10.92 | 0.68 | - | ||
| 2025/11 | 3.26 | -12.62 | 8.14 | 38.86 | 4.76 | 10.61 | 0.7 | - | ||
| 2025/10 | 3.73 | 3.45 | 10.96 | 35.6 | 4.46 | 10.86 | 0.69 | - | ||
| 2025/9 | 3.61 | 2.61 | 6.74 | 31.86 | 3.75 | 10.66 | 0.63 | - | ||
| 2025/8 | 3.52 | -0.36 | 2.1 | 28.25 | 3.38 | 10.84 | 0.62 | - | ||
| 2025/7 | 3.53 | -6.8 | 8.15 | 24.74 | 3.57 | 10.63 | 0.63 | - | ||
| 2025/6 | 3.79 | 14.47 | 7.48 | 21.21 | 2.84 | 10.7 | 0.6 | - | ||
| 2025/5 | 3.31 | -8.19 | -1.16 | 17.42 | 1.89 | 10.61 | 0.61 | - | ||
| 2025/4 | 3.6 | -2.52 | -12.05 | 14.11 | 2.63 | 10.41 | 0.62 | - | ||
| 2025/3 | 3.7 | 18.94 | 16.13 | 10.5 | 8.87 | 10.5 | 0.61 | - | ||
| 2025/2 | 3.11 | -15.94 | 11.2 | 6.81 | 5.3 | 10.44 | 0.62 | - | ||
| 2025/1 | 3.7 | 1.7 | 0.8 | 3.7 | 0.8 | 10.35 | 0.62 | - | ||
| 2024/12 | 3.64 | 20.53 | 4.13 | 40.73 | 4.54 | 10.02 | 0.67 | - | ||
| 2024/11 | 3.02 | -10.34 | -5.12 | 37.09 | 4.58 | 9.76 | 0.69 | - | ||
| 2024/10 | 3.37 | -0.47 | 6.86 | 34.07 | 5.53 | 10.19 | 0.66 | - | ||
| 2024/9 | 3.38 | -1.83 | 4.46 | 30.71 | 5.39 | 10.09 | 0.68 | - | ||
| 2024/8 | 3.44 | 5.54 | -2.27 | 27.33 | 5.51 | 10.23 | 0.67 | - | ||
| 2024/7 | 3.26 | -7.37 | 5.89 | 23.88 | 6.74 | 10.14 | 0.68 | - | ||
| 2024/6 | 3.52 | 5.26 | 4.34 | 20.62 | 6.87 | 10.97 | 0.57 | - | ||
| 2024/5 | 3.35 | -18.31 | 8.39 | 17.09 | 7.41 | 10.63 | 0.59 | - | ||
| 2024/4 | 4.1 | 28.71 | 32.36 | 13.75 | 7.17 | 10.08 | 0.62 | - | ||
| 2024/3 | 3.18 | 13.89 | -8.51 | 9.65 | -0.83 | 9.65 | N/A | - | ||
| 2024/2 | 2.8 | -23.8 | -1.78 | 6.46 | 3.43 | 9.96 | N/A | - | ||
| 2024/1 | 3.67 | 5.06 | 7.8 | 3.67 | 7.8 | 10.34 | N/A | - | ||
| 2023/12 | 3.49 | 9.81 | 1.78 | 38.96 | -16.92 | 9.82 | N/A | - | ||
| 2023/11 | 3.18 | 0.97 | 4.2 | 35.47 | -18.4 | 9.57 | N/A | - | ||
| 2023/10 | 3.15 | -2.71 | 1.49 | 32.29 | -20.11 | 9.91 | N/A | - | ||
| 2023/9 | 3.24 | -8.16 | -7.3 | 29.14 | -21.91 | 9.84 | N/A | - | ||
| 2023/8 | 3.53 | 14.35 | 9.51 | 25.9 | -23.41 | 9.98 | N/A | - | ||
| 2023/7 | 3.08 | -8.73 | -2.95 | 22.37 | -26.88 | 9.55 | N/A | - | ||
| 2023/6 | 3.38 | 9.34 | -27.0 | 19.29 | -29.65 | 9.56 | N/A | - | ||
| 2023/5 | 3.09 | -0.24 | -68.53 | 15.91 | -30.19 | 9.66 | N/A | 111年同期因有新增快篩試劑銷售業務而本年度因疫情趨緩銷售減少 | ||
| 2023/4 | 3.1 | -11.03 | -2.08 | 12.83 | -1.19 | 9.42 | N/A | - | ||
| 2023/3 | 3.48 | 22.26 | 1.89 | 9.73 | -0.9 | 9.73 | N/A | - | ||
| 2023/2 | 2.85 | -16.36 | 20.12 | 6.25 | -2.4 | 9.68 | N/A | - | ||
| 2023/1 | 3.4 | -0.8 | -15.63 | 3.4 | -15.63 | 9.89 | N/A | - | ||
| 2022/12 | 3.43 | 12.42 | 6.12 | 46.9 | 27.29 | 9.59 | N/A | - | ||
| 2022/11 | 3.05 | -1.64 | 4.77 | 43.47 | 29.33 | 9.65 | N/A | - | ||
| 2022/10 | 3.1 | -11.15 | 7.83 | 40.41 | 31.66 | 9.81 | N/A | - | ||
| 2022/9 | 3.49 | 8.49 | 8.57 | 37.31 | 34.13 | 9.89 | N/A | - | ||
| 2022/8 | 3.22 | 1.34 | 6.14 | 33.82 | 37.47 | 11.02 | N/A | - | ||
| 2022/7 | 3.18 | -31.35 | 15.23 | 30.6 | 41.87 | 17.62 | N/A | - | ||
| 2022/6 | 4.63 | -52.86 | 12.49 | 27.42 | 45.78 | 17.61 | N/A | - | ||
| 2022/5 | 9.82 | 210.45 | 236.11 | 22.8 | 55.09 | 16.39 | N/A | 因新增快篩試劑銷售業務，故本月及本年累計營業額較去年同期增加 | ||
| 2022/4 | 3.16 | -7.41 | 6.82 | 12.98 | 10.21 | 8.95 | N/A | - | ||
| 2022/3 | 3.42 | 44.14 | 7.36 | 9.82 | 11.34 | 9.82 | N/A | - | ||
| 2022/2 | 2.37 | -41.26 | -12.97 | 6.4 | 13.59 | 9.64 | N/A | - | ||
| 2022/1 | 4.03 | 24.77 | 38.4 | 4.03 | 38.4 | 10.18 | N/A | - | ||
| 2021/12 | 3.23 | 11.0 | -0.32 | 36.84 | 7.34 | 9.02 | N/A | - | ||
| 2021/11 | 2.91 | 1.22 | 10.08 | 33.61 | 8.14 | 9.01 | N/A | - | ||
| 2021/10 | 2.88 | -10.54 | 6.33 | 30.69 | 7.96 | 9.13 | N/A | - | ||
| 2021/9 | 3.22 | 6.06 | 2.67 | 27.82 | 8.13 | 9.01 | N/A | - | ||
| 2021/8 | 3.03 | 10.02 | 10.06 | 24.6 | 8.89 | 9.9 | N/A | - | ||
| 2021/7 | 2.76 | -32.98 | -3.64 | 21.57 | 8.72 | 9.79 | N/A | - | ||
| 2021/6 | 4.11 | 40.82 | 31.56 | 18.81 | 10.81 | 0.0 | N/A | - | ||
| 2021/5 | 2.92 | -1.32 | 12.14 | 14.7 | 6.12 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2026/1 | 4.21 | 2025/1 | 3.7 | 2024/1 | 3.67 | 2023/1 | 3.4 | 2022/1 | 4.03 |
| 2026/2 | 3.32 | 2025/2 | 3.11 | 2024/2 | 2.8 | 2023/2 | 2.85 | 2022/2 | 2.37 |
| 2026/3 | 3.92 | 2025/3 | 3.7 | 2024/3 | 3.18 | 2023/3 | 3.48 | 2022/3 | 3.42 |
| 2026/4 | 3.7 | 2025/4 | 3.6 | 2024/4 | 4.1 | 2023/4 | 3.1 | 2022/4 | 3.16 |
| N/A | N/A | 2025/5 | 3.31 | 2024/5 | 3.35 | 2023/5 | 3.09 | 2022/5 | 9.82 |
| N/A | N/A | 2025/6 | 3.79 | 2024/6 | 3.52 | 2023/6 | 3.38 | 2022/6 | 4.63 |
| N/A | N/A | 2025/7 | 3.53 | 2024/7 | 3.26 | 2023/7 | 3.08 | 2022/7 | 3.18 |
| N/A | N/A | 2025/8 | 3.52 | 2024/8 | 3.44 | 2023/8 | 3.53 | 2022/8 | 3.22 |
| N/A | N/A | 2025/9 | 3.61 | 2024/9 | 3.38 | 2023/9 | 3.24 | 2022/9 | 3.49 |
| N/A | N/A | 2025/10 | 3.73 | 2024/10 | 3.37 | 2023/10 | 3.15 | 2022/10 | 3.1 |
| N/A | N/A | 2025/11 | 3.26 | 2024/11 | 3.02 | 2023/11 | 3.18 | 2022/11 | 3.05 |
| N/A | N/A | 2025/12 | 3.92 | 2024/12 | 3.64 | 2023/12 | 3.49 | 2022/12 | 3.43 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 26Q1 (8) | 0.19 | -5.0 | -5.0 |
| 25Q4 (7) | 0.2 | 122.22 | 0.0 |
| 25Q3 (6) | 0.09 | -55.0 | -52.63 |
| 25Q2 (5) | 0.2 | 0.0 | 11.11 |
| 25Q1 (4) | 0.2 | 0.0 | 0.0 |
| 24Q4 (3) | 0.2 | 5.26 | 0.0 |
| 24Q3 (2) | 0.19 | 5.56 | 0.0 |
| 24Q2 (1) | 0.18 | 0.0 | 0.0 |